Coronavirus vaccines: Big pharma's next cash cow?
November 13, 2020
81,708
1,091
393
1.82%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Dw News Episodes Around November 13, 2020
See what was published immediately before and after this episode.
11:48Now PlayingCoronavirus vaccines: Big pharma's next cash cow?
YouTube Description
as posted by the channelTen corona vaccine candidates are now in late-stage trials. The world is already celebrating what could be the breakthrough in fighting COVID-19. Pharmaceutical companies are also cheering. The public sector has invested billions more in development. but it's the private sector that will rake in the cash. Under existing agreements, they control the price and get the profits. Pharma firms say development is expensive and time consuming. and results are not guaranteed.
It's a gamble for governments too, which are reserving millions of doses of what they hope will work. Still other coronaviruses could come along. Vaccines could become big pharma's new cash cow.
For more news go to
Follow DW on social media:
Für Videos in deutscher Sprache besuchen Sie
#Coronavirus #Vaccine #Pharma
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.